Breakdown | TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 77.82B | 75.93B | 77.77B | 71.98B | 62.27B | 55.25B |
Gross Profit | 30.43B | 29.82B | 29.65B | 25.85B | 22.74B | 19.89B |
EBITDA | 15.97B | 15.34B | 15.27B | 13.48B | 11.64B | 6.58B |
Net Income | 9.84B | 8.30B | 7.95B | 3.72B | 6.16B | 4.03B |
Balance Sheet | ||||||
Total Assets | 162.59B | 147.81B | 145.07B | 151.50B | 139.61B | 123.90B |
Cash, Cash Equivalents and Short-Term Investments | 23.93B | 10.22B | 11.13B | 12.99B | 12.05B | 16.72B |
Total Debt | 57.52B | 47.92B | 46.60B | 50.64B | 48.70B | 44.57B |
Total Liabilities | 99.42B | 91.58B | 92.01B | 96.70B | 90.33B | 84.07B |
Stockholders Equity | 57.57B | 51.26B | 47.79B | 48.90B | 44.37B | 36.39B |
Cash Flow | ||||||
Free Cash Flow | 9.75B | 9.58B | 10.09B | 8.16B | 8.27B | 7.36B |
Operating Cash Flow | 12.01B | 11.66B | 12.24B | 10.24B | 10.00B | 8.86B |
Investing Cash Flow | -5.97B | -3.28B | -3.18B | -2.49B | -15.49B | -5.18B |
Financing Cash Flow | -1.05B | -8.88B | -8.73B | -7.50B | 785.00M | 3.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | €177.82B | 18.15 | 15.14% | 2.31% | -0.04% | 33.26% | |
75 Outperform | €10.20B | 26.95 | 16.56% | 1.87% | 1.79% | 0.06% | |
73 Outperform | $80.60B | 375.55 | 1.79% | ― | 17.17% | ― | |
72 Outperform | €1.62B | 15.36 | 4.78% | 2.97% | -10.85% | -3.64% | |
65 Neutral | €4.11B | 14.29 | 15.37% | 2.00% | 10.25% | 20.72% | |
65 Neutral | $10.84B | 16.29 | 5.52% | 2.09% | 3.14% | -29.96% | |
65 Neutral | €3.43B | 11.88 | 12.41% | 2.38% | -2.78% | -3.44% |